These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8336397

  • 1. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K, Ito Y, Uriu K, Eto S.
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [Abstract] [Full Text] [Related]

  • 2. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
    Kaizu K, Ito Y, Uriu K, Komine N, Hashimoto O, Eto S.
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
    [Abstract] [Full Text] [Related]

  • 3. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
    Kaizu K, Ito Y, Uriu K, Eto S.
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
    [Abstract] [Full Text] [Related]

  • 4. [Urinary cross-linked FDP in various renal diseases].
    Inuma H.
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
    [Abstract] [Full Text] [Related]

  • 5. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K, Dohi K, Fujii Y, Ishikawa H.
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T, Magari Y, Mizunaga S, Okabe E, Sumie A, Ishii T, Tomo T, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
    [Abstract] [Full Text] [Related]

  • 9. Role of intrarenal coagulation and anticoagulant therapy in the progression of diabetic nephropathy.
    Kaizu K, Uriu K, Hashimoto O, Morita E, Eto S, Suzuki H.
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):35-42. PubMed ID: 8336398
    [Abstract] [Full Text] [Related]

  • 10. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K, Yasumuro Y, Taki M, Suzuki N, Tanabe H, Ichikawa Y.
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [Abstract] [Full Text] [Related]

  • 11. [Serum FDP assay with latex photometric immunoassay and its analysis by immunoblotting].
    Okumura N, Kagiya H, Saito H, Katsuyama T, Kanai M.
    Rinsho Byori; 1991 Jan; 39(1):76-82. PubMed ID: 2008047
    [Abstract] [Full Text] [Related]

  • 12. [FDP-E--quantitative analysis by LPIA (latex photometric immunoassay) method].
    Furusaki F, Sudo T, Tsutsui S.
    Rinsho Byori; 1989 Apr; Spec No 81():168-75. PubMed ID: 2754804
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
    Shibata T, Magari Y, Perparim K, Sumie A, Ishii T, Tomo T, Sato J, Yasumori R, Nasu M.
    Nephron; 1995 Apr; 69(1):54-8. PubMed ID: 7891798
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL, Francis CW, Knutson DW, Marder VJ.
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of urinary fibrinogen degradation products in renal disease: study with two methods and correlation with histological findings of intraglomerular coagulation.
    Loschiavo C, Previato G, Valvo E, Lupo A, Tessitore N, Chiaramonte S, Maschio G.
    Nephron; 1981 Jun; 28(4):200-3. PubMed ID: 7029322
    [Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K, Wada H, Abe Y, Tomatsu H, Nishioka J, Nobori T.
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [Abstract] [Full Text] [Related]

  • 19. Fibrinogen degradation products in acute renal failure of the newborn.
    Assadi F, Delivoria-Papadopoulos M, Pereira G, Peckham G, Norman M.
    Clin Nephrol; 1983 Feb; 19(2):74-81. PubMed ID: 6839555
    [Abstract] [Full Text] [Related]

  • 20. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP, Williams TK, Legendre AM.
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.